trending Market Intelligence /marketintelligence/en/news-insights/trending/Ay5fVFqsk31rJa8jC7WDfQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Creat Group to take over Biotest in €1.3B business combination agreement

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Creat Group to take over Biotest in €1.3B business combination agreement

Chinese investment firm Creat Group Corp. will make a voluntary public takeover offer for all outstanding publicly traded ordinary and preference shares of Biotest AG under a five-year business combination agreement.

Biotest shareholders will be offered 28.50 in cash per ordinary share and 19 in cash per preference share in a deal that values Biotest at 1.3 billion, including net debt.

The offer will be subject to certain closing conditions, including regulatory approvals and a minimum acceptance threshold of 75% of Biotest's ordinary shares. Members of the management board plan to accept the offer and to tender their personal shares.

Biotest's majority shareholder OGEL GmbH supports the deal and signed an agreement with Creat to irrevocably accept the offer and to tender its shares, which represent 50.61% of all outstanding ordinary shares.

Creat agreed to keep Biotest's corporate seat in Dreieich, to maintain Biotest's corporate name, brand and product names, and also to increase employment levels consistent with the current management business plan and to adhere to existing shop and collective bargaining agreements and employee co-determination.

The offer document is subject to approval by the German Federal Financial Supervisory Authority.

Credit Suisse is acting as financial adviser and Ashurst LLP is acting as legal adviser to Biotest.